The OnSite COVID-19 Ag Rapid Test is a lateral flow immunoassay for the qualitative detection of SARS-CoV-2 virus in nasopharyngeal (NP), or nasal swab specimens from individuals who are suspected of COVID-19, within the first seven days of the onset of symptoms.
Currently, the laboratory method for detecting COVID-19 is RT-PCR. However, this method requires sophisticated equipment and highly trained laboratory technicians. The OnSite COVID-19 Ag Rapid Test is easy to use, cost-efficient and can be done at the point of care.
The test is intended for use by healthcare providers or personnel trained in rapid test procedure.